Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Asset Writedowns and Impairment (2016)

Historic Asset Writedowns and Impairment for Chemours (CC) over the last 2 years, with Q3 2016 value amounting to $46.0 million.

  • Chemours' Asset Writedowns and Impairment rose 222.22% to $46.0 million in Q3 2016 from the same period last year, while for Sep 2016 it was $157.0 million, marking a year-over-year increase of 24888.89%. This contributed to the annual value of $48.0 million for FY2015, which is N/A changed from last year.
  • According to the latest figures from Q3 2016, Chemours' Asset Writedowns and Impairment is $46.0 million, which was up 222.22% from $63.0 million recorded in Q2 2016.
  • Chemours' Asset Writedowns and Impairment's 5-year high stood at $63.0 million during Q2 2016, with a 5-year trough of $3.0 million in Q4 2015.